Cancer susceptibility of beta HPV49 E6 and E7 transgenic mice to 4-nitroquinoline 1-oxide treatment correlates with mutational signatures of tobacco exposure

We have previously showed that a transgenic (Tg) mouse model with cytokeratin 14 promoter (K14)-driven expression of E6 and E7 from beta-3 HPV49 in the basal layer of the epidermis and of the mucosal epithelia of the digestive tract (K14 HPV49 E6/E7 Tg mice) are highly susceptible to upper digestive...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Viarisio, Daniele (VerfasserIn) , Robitaille, Alexis (VerfasserIn) , Müller-Decker, Karin (VerfasserIn) , Flechtenmacher, Christa (VerfasserIn) , Gissmann, Lutz (VerfasserIn) , Tommasino, Massimo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 24 September 2019
In: Virology
Year: 2019, Jahrgang: 538, Pages: 53-60
ISSN:1096-0341
DOI:10.1016/j.virol.2019.09.010
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.virol.2019.09.010
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0042682219302752
Volltext
Verfasserangaben:Daniele Viarisio, Alexis Robitaille, Karin Müller-Decker, Christa Flechtenmacher, Lutz Gissmann, Massimo Tommasino

MARC

LEADER 00000caa a2200000 c 4500
001 1695025261
003 DE-627
005 20220818045004.0
007 cr uuu---uuuuu
008 200420s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.virol.2019.09.010  |2 doi 
035 |a (DE-627)1695025261 
035 |a (DE-599)KXP1695025261 
035 |a (OCoLC)1341315862 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Viarisio, Daniele  |e VerfasserIn  |0 (DE-588)1022720228  |0 (DE-627)717030717  |0 (DE-576)365832855  |4 aut 
245 1 0 |a Cancer susceptibility of beta HPV49 E6 and E7 transgenic mice to 4-nitroquinoline 1-oxide treatment correlates with mutational signatures of tobacco exposure  |c Daniele Viarisio, Alexis Robitaille, Karin Müller-Decker, Christa Flechtenmacher, Lutz Gissmann, Massimo Tommasino 
264 1 |c 24 September 2019 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 20.04.2020 
520 |a We have previously showed that a transgenic (Tg) mouse model with cytokeratin 14 promoter (K14)-driven expression of E6 and E7 from beta-3 HPV49 in the basal layer of the epidermis and of the mucosal epithelia of the digestive tract (K14 HPV49 E6/E7 Tg mice) are highly susceptible to upper digestive tract carcinogenesis upon exposure to 4-nitroquinoline 1-oxide (4NQO). Using whole-exome sequencing, we show that in K14 HPV49 E6/E7 Tg mice, development of 4NQO-induced cancers tightly correlates with the accumulation of somatic mutations in cancer-related genes. The mutational signature in 4NQO-treated mice was similar to the signature observed in humans exposed to tobacco smoking and tobacco chewing. Similar results were obtained with K14 Tg animals expressing mucosal high-risk HPV16 E6 and E7 oncogenes. Thus, beta-3 HPV49 share some functional similarities with HPV16 in Tg animals. 
650 4 |a 4-Nitroquinoline 1-oxide 
650 4 |a Beta HPV types 
650 4 |a Mutational signatures of tobacco exposure 
650 4 |a Upper-digestive tract cancer 
700 1 |a Robitaille, Alexis  |e VerfasserIn  |4 aut 
700 1 |a Müller-Decker, Karin  |e VerfasserIn  |0 (DE-588)1084651351  |0 (DE-627)848630556  |0 (DE-576)169302431  |4 aut 
700 1 |a Flechtenmacher, Christa  |e VerfasserIn  |0 (DE-588)1022413147  |0 (DE-627)716965283  |0 (DE-576)365291951  |4 aut 
700 1 |a Gissmann, Lutz  |d 1949-  |e VerfasserIn  |0 (DE-588)1153082020  |0 (DE-627)1014479541  |0 (DE-576)500060126  |4 aut 
700 1 |a Tommasino, Massimo  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Virology  |d San Diego, Calif. [u.a.] : Elsevier, 1955  |g 538(2019), Seite 53-60  |h Online-Ressource  |w (DE-627)268130248  |w (DE-600)1471925-3  |w (DE-576)104194081  |x 1096-0341  |7 nnas  |a Cancer susceptibility of beta HPV49 E6 and E7 transgenic mice to 4-nitroquinoline 1-oxide treatment correlates with mutational signatures of tobacco exposure 
773 1 8 |g volume:538  |g year:2019  |g pages:53-60  |g extent:8  |a Cancer susceptibility of beta HPV49 E6 and E7 transgenic mice to 4-nitroquinoline 1-oxide treatment correlates with mutational signatures of tobacco exposure 
856 4 0 |u https://doi.org/10.1016/j.virol.2019.09.010  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0042682219302752  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200420 
993 |a Article 
994 |a 2019 
998 |g 1022413147  |a Flechtenmacher, Christa  |m 1022413147:Flechtenmacher, Christa  |d 910000  |d 912000  |e 910000PF1022413147  |e 912000PF1022413147  |k 0/910000/  |k 1/910000/912000/  |p 4 
999 |a KXP-PPN1695025261  |e 3627530675 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1016/j.virol.2019.09.010"],"eki":["1695025261"]},"recId":"1695025261","name":{"displayForm":["Daniele Viarisio, Alexis Robitaille, Karin Müller-Decker, Christa Flechtenmacher, Lutz Gissmann, Massimo Tommasino"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"8 S."}],"relHost":[{"title":[{"title":"Virology","title_sort":"Virology"}],"part":{"text":"538(2019), Seite 53-60","pages":"53-60","extent":"8","volume":"538","year":"2019"},"disp":"Cancer susceptibility of beta HPV49 E6 and E7 transgenic mice to 4-nitroquinoline 1-oxide treatment correlates with mutational signatures of tobacco exposureVirology","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 12.08.20"],"origin":[{"publisherPlace":"San Diego, Calif. [u.a.] ; Orlando, Fla.","dateIssuedKey":"1955","publisher":"Elsevier ; Academic Press","dateIssuedDisp":"1955-"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"268130248","id":{"zdb":["1471925-3"],"eki":["268130248"],"issn":["1096-0341"]},"pubHistory":["1.1955 -"]}],"title":[{"title_sort":"Cancer susceptibility of beta HPV49 E6 and E7 transgenic mice to 4-nitroquinoline 1-oxide treatment correlates with mutational signatures of tobacco exposure","title":"Cancer susceptibility of beta HPV49 E6 and E7 transgenic mice to 4-nitroquinoline 1-oxide treatment correlates with mutational signatures of tobacco exposure"}],"person":[{"role":"aut","display":"Viarisio, Daniele","given":"Daniele","family":"Viarisio"},{"given":"Alexis","family":"Robitaille","display":"Robitaille, Alexis","role":"aut"},{"display":"Müller-Decker, Karin","role":"aut","given":"Karin","family":"Müller-Decker"},{"given":"Christa","family":"Flechtenmacher","role":"aut","display":"Flechtenmacher, Christa"},{"given":"Lutz","family":"Gissmann","display":"Gissmann, Lutz","role":"aut"},{"role":"aut","display":"Tommasino, Massimo","family":"Tommasino","given":"Massimo"}],"origin":[{"dateIssuedDisp":"24 September 2019","dateIssuedKey":"2019"}],"note":["Gesehen am 20.04.2020"]} 
SRT |a VIARISIODACANCERSUSC2420